Primary Care Clinics in Decatur, TN Accepting Medicare
5 Primary Care Clinics found. Showing 1 - 5
 Restoration Clinic Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 16850 State Highway 58 South, Suite A, Decatur, TN 37322 Phone: 423-506-3781 Fax: 423-454-0125 |
Restoration Clinic Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 17619 State Highway 58 N Ste C, Decatur, TN 37322 Phone: 423-506-3781 |
R. Shane Roberts, M.d., Inc. Family Medicine Medicare: Medicare Enrolled Practice Location: 398 N Main St, Decatur, TN 37322 Phone: 423-334-2222 Fax: 423-334-2255 |
R. Shane Roberts, M.d., Inc. Family Medicine Medicare: Medicare Enrolled Practice Location: 398 N Main St, Decatur, TN 37322 Phone: 423-334-2222 Fax: 423-334-2255 |
Meigs County Primary Care Center Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 305 River Rd, Decatur, TN 37322 Phone: 423-334-4154 Fax: 423-334-4195 |
News Archive
Plantain and broccoli fiber help in Crohn's disease: Study
New research suggests that plant fibers in plantains and broccoli can help prevent relapses of Crohn's disease. This disease is a long term disease of the gut that is characterized by inflammation of the lining of the digestive system, with symptoms including diarrhea and abdominal pain. Crohn's disease affects between 400,000 and 600,000 people in North America. Scientists believe that rise in processed food and decrease in fibers in diet could be a reason for rise of incidence of this disease.
Philips and Oxford University Hospitals NHS Foundation Trust join hands to set up digital pathology network
Royal Philips, a global leader in health technology, and Oxford University Hospitals (OUH) NHS Foundation Trust, today announced plans to create a digital pathology network to help drive faster and more efficient diagnoses for patients.
Rising awareness, new product alternatives to boost prospects of European sleep apnea diagnostics market
Low levels of awareness among patients and physicians about sleep apnea are hindering the uptake of related diagnostics. Increased knowledge about this breathing disorder together with the emergence of new alternatives to current diagnostics tools is set to aid in market expansion.
AstraZeneca completes enrollment in phase III studies of cancer drug vandetanib
AstraZeneca has announced that it has completed patient enrollment in two pivotal Phase III studies for vandetanib, the company's investigational, once-daily oral anti-cancer drug, for the second-line treatment of non-small cell lung cancer (NSCLC).
› Verified 9 days ago